Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.
We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.